Concepedia

Christian Schrenk

CS

4

Publications

101

Citations

4

H-Index

2019

Active since

Affiliations

Heinrich Heine University Düsseldorf(Current)

Christian Schrenk is an author at Heinrich Heine University Düsseldorf specializing in medicine, pharmacology, and cancer research.

ORCID

Top concepts

Publications per year

2019–2020

4

Publications

4

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines

Jan J. Bandolik, Alexandra Hamacher, Christian Schrenk et al. · International Journal of Molecular Sciences · 2019 · 47 citations · Full text

Novel alkoxyamide-based histone deacetylase inhibitors reverse cisplatin resistance in chemoresistant cancer cells

Yodita Asfaha, Christian Schrenk, Leandro A. Alves Avelar et al. · Bioorganic & Medicinal Chemistry · 2019 · 23 citations · Full text

, , +8

Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors

Leandro A. Alves Avelar, Christian Schrenk, Melf Sönnichsen et al. · European Journal of Medicinal Chemistry · 2020 · 20 citations · Full text

, , +11

Novel α,β-unsaturated hydroxamic acid derivatives overcome cisplatin resistance

Marc Pflieger, Alexandra Hamacher, Taner Öz et al. · Bioorganic & Medicinal Chemistry · 2019 · 11 citations · Full text

, , +7

Rows per page

1–4 of 4